Immunotherapy Infiltrates Small Cell Lung Cancer Treatment But Biomarkers Remain Elusive

Immunotherapy Infiltrates Small Cell Lung Cancer Treatment, But Biomarkers Remain Elusive

Jason Niu, MD, PhD, discusses the evolution in the treatment paradigm for patients with extensive-stage small cell lung cancer.

More From BioPortfolio on "Immunotherapy Infiltrates Small Cell Lung Cancer Treatment, But Biomarkers Remain Elusive"